DrugsControl Media Services

News Detail

First Acute Kidney Injury Diagnostic Test Wins FDA Clearance (08-12-2023)

Ohio, 7 Dec 2023: The first acute kidney injury (AKI) biomarker test to receive U.S. Food and Drug Administration 510(k) clearance for pediatric use in the United States was discovered here at Cincinnati Children’s.View Details

Source : Cincinnati Children’s
kidney injury (AKI) biomarker test Cincinnati Children’s neutrophil gelatinase-associated lipocalin (NGAL) test ProNephro AKI test

Related News